Nicholas P. Gall, M.Sc., M.D., M.R.C.P.; Francis D. Murgatroyd, M.A., F.R.C.P., F.A.C.C. From these and subsequent studies, it became clear that cardioversion was ...
ANKARA, TURKEY — A strategy that takes advantage of the C in ICD (implantable cardioverter defibrillator), in which the device delivers a shock aimed at restoring sinus rhythm in patients with atrial ...
(HealthDay)—An advanced practice provider (APP) can safely perform electrical cardioversion (CV) for atrial fibrillation, according to a study published online June 28 in JACC: Clinical ...
Patients with atrial fibrillation (AF) who need anticoagulation before undergoing electrical correction of their abnormal heartbeat (cardioversion) may benefit from treatment with edoxoban - a ...
The conventional treatment strategy for patients with atrial fibrillation who are to undergo electrical cardioversion is to prescribe warfarin for anticoagulation for three weeks before cardioversion.
The drug-shock strategy was more effective for patients experiencing atrial fibrillation for the first time and for patients younger than 70 years, the researchers said. Both the anti-arrhythmia drug ...
VANCOUVER, Feb. 13, 2014 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME) (TSX: COM) today announced that a poster titled "Medical conversion with Vernakalant on postoperative cardio-surgical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results